Physician profile
Mark Hellerman
NPI 1033614045
$2,047.83
in general payments reported to CMS, 2019-2025
13 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.20 · 2023: $122 · 2024: $1,521 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,954.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $818.84 | 2024-2025 | Cardiomems, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $247.07 | 2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $242.13 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $201.33 | 2022-2024 | |
| Boston Scientific Corporation | $143.68 | 2023-2024 | Avvigo Guidance System, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.22 | 2022-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $86.02 | 2025 | |
| Novartis Pharmaceuticals Corporation | $56.05 | 2024 | |
| Medtronic, INC. | $51.41 | 2024 | Cobalt Dr Mri Surescan |
| Chiesi USA, INC. | $38.42 | 2023-2024 | Kengreal, Cleviprex |
| Penumbra, INC. | $28.61 | 2025 | Indigo System |
| Heartflow, INC. | $26.86 | 2025 | |
| Abiomed | $21.19 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hellerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.